Cementos Bio-B
Cementos Bio Bio S.A. engages in the production and sale of cement, lime, and concrete products in Chile and internationally. The company operates through Cement and Lime segments. It offers ready-mixed concrete, gypsum, and limestone products. The company is also involved in the manufacture and sale of lime for use in the extraction of silver, gold, lithium, and iodine applications, as well as c… Read more
Cementos Bio-B (CEMENTOS) - Total Liabilities
Latest total liabilities as of December 2025: CL$239.33 Billion CLP
Based on the latest financial reports, Cementos Bio-B (CEMENTOS) has total liabilities worth CL$239.33 Billion CLP as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Cementos Bio-B - Total Liabilities Trend (2014–2025)
This chart illustrates how Cementos Bio-B's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Cementos Bio-B Competitors by Total Liabilities
The table below lists competitors of Cementos Bio-B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Digital Brands Group Inc
NASDAQ:DBGIW
|
USA | $23.27 Million |
|
Lifevantage Corporation
NASDAQ:LFVN
|
USA | $28.18 Million |
|
Shougang Concord Century Holdings Limited
F:CW7
|
Germany | €1.80 Billion |
|
Vascon Engineers Limited
NSE:VASCONEQ
|
India | ₹10.70 Billion |
|
e-Credible Co. Ltd
KQ:092130
|
Korea | ₩10.13 Billion |
|
India Pesticides Limited
NSE:IPL
|
India | ₹3.24 Billion |
|
Jinxin Technology Holding Company American Depositary Shares
NASDAQ:NAMI
|
USA | $91.95 Million |
|
STEP Energy Services Ltd
PINK:SNVVF
|
USA | $142.07 Million |
Liability Composition Analysis (2014–2025)
This chart breaks down Cementos Bio-B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.38 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.83 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cementos Bio-B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cementos Bio-B (2014–2025)
The table below shows the annual total liabilities of Cementos Bio-B from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CL$239.33 Billion | -4.54% |
| 2024-12-31 | CL$250.72 Billion | +6.68% |
| 2023-12-31 | CL$235.01 Billion | +0.39% |
| 2022-12-31 | CL$234.09 Billion | +1.06% |
| 2021-12-31 | CL$231.64 Billion | +14.35% |
| 2020-12-31 | CL$202.57 Billion | +1.02% |
| 2019-12-31 | CL$200.52 Billion | -7.92% |
| 2018-12-31 | CL$217.78 Billion | -0.56% |
| 2017-12-31 | CL$219.00 Billion | -18.74% |
| 2016-12-31 | CL$269.52 Billion | -2.78% |
| 2015-12-31 | CL$277.22 Billion | +6.96% |
| 2014-12-31 | CL$259.17 Billion | -- |